Medtronic (MDT) operating cash flow was $7.3B in FY2026 (+4% YoY). The tables below show the complete quarterly and annual operating cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Cash Flow
Fiscal Year
Operating Cash Flow
YoY
2026
$7.3B
+4%
2025
$7.0B
+4%
2024
$6.8B
+12%
2023
$6.0B
-18%
2022
$7.3B
+18%
2021
$6.2B
-14%
2020
$7.2B
+3%
2019
$7.0B
+50%
2018
$4.7B
-32%
2017
$6.9B
+32%
2016
$5.2B
+6%
2015
$4.9B
-1%
2014
$5.0B
+0%
2013
$4.9B
Recent Quarterly Operating Cash Flow
Quarter
Operating Cash Flow
Q2 2026
$1.8B
Q1 2026
$2.6B
Q3 2025
$925M
Q2 2025
$1.1B
Q1 2025
$2.5B
Q3 2024
$958M
Q2 2024
$986M
Q1 2024
$2.8B
Q3 2023
$661M
Q2 2023
$875M
Q1 2023
$2.5B
Q3 2022
$922M
Source: MDT on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.